Drug Trial Radar · NCT07712692
Evaluation of NWRD09 for HPV-16 Related Cervical HSIL
Last checked: Nov 19, 2026Latest source record: Jul 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
156
Planned (sponsor's estimate)
Start
Aug 1, 2026
Primary completion
Jun 30, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Newish Biotech (Wuxi) Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo controlled Phase 2 study to determine the efficacy and safety of NWRD09 administered by intramuscular (IM) injection in adult women with histologically confirmed cervical high grade squamous intraepithelial lesion (HSIL) (cervical intraepithelial neoplasia grade 2 \[CIN2\] or grade 3 \[CIN3\]) associated with human papillomavirus (HPV) 16.
Conditions
- High-grade Squamous Intraepithelial Lesion (HSIL)
Interventions
NWRD09 InjectionBiological
NWRD09 administered by intramuscular injection at weeks 0, 2, 4, and 12.
NWRD09 PlaceboBiological
Placebo administered by intramuscular injection at weeks 0, 2, 4, and 12.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants with Histopathological Regression of Cervical Lesions to non-HSIL (LSIL/CIN1 or no lesion) at week 24.Time frame: Week24
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Dalian Maternal and Child Health Hospital
Dalian, China
Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
The First Hospital Affiliated to AMU (SOUTHWEST HOSPITAL)
Chongqing, Chongqing Municipality, China
Gansu Provincial Maternity and Child-care Hospital / Gansu Provincial central Hospital
Lanzhou, Gansu, China
Affiliated Hospital of Hebei University
Baoding, Hebei, China
The Second Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Nanjing Maternity and Child Health Care Hospital
Nanjing, Jiangsu, China
The Second Hospital of Jilin University
Changchun, Jilin, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Shanxi Maternal and Child Health Hospital
Taiyuan, Shanxi, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.